60 Degrees Pharmaceuticals (SXTP) Competitors $1.40 -0.02 (-1.41%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$1.40 0.00 (0.00%) As of 09/12/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SXTP vs. NAII, PASG, AKTX, NNVC, NEUP, SNYR, CTXR, TAOX, SONN, and AYTUShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include Natural Alternatives International (NAII), Passage Bio (PASG), Akari Therapeutics (AKTX), NanoViricides (NNVC), Neuphoria Therapeutics (NEUP), Synergy CHC (SNYR), Citius Pharmaceuticals (CTXR), Synaptogenix (TAOX), Sonnet BioTherapeutics (SONN), and Aytu BioPharma (AYTU). These companies are all part of the "pharmaceutical products" industry. 60 Degrees Pharmaceuticals vs. Its Competitors Natural Alternatives International Passage Bio Akari Therapeutics NanoViricides Neuphoria Therapeutics Synergy CHC Citius Pharmaceuticals Synaptogenix Sonnet BioTherapeutics Aytu BioPharma Natural Alternatives International (NASDAQ:NAII) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations. Do analysts recommend NAII or SXTP? 60 Degrees Pharmaceuticals has a consensus price target of $3.00, suggesting a potential upside of 114.29%. Given 60 Degrees Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe 60 Degrees Pharmaceuticals is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.0060 Degrees Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, NAII or SXTP? Natural Alternatives International has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, 60 Degrees Pharmaceuticals has a beta of 2.73, meaning that its stock price is 173% more volatile than the S&P 500. Does the media favor NAII or SXTP? In the previous week, Natural Alternatives International had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for Natural Alternatives International and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.91 beat Natural Alternatives International's score of 1.46 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Natural Alternatives International Positive 60 Degrees Pharmaceuticals Very Positive Do institutionals and insiders hold more shares of NAII or SXTP? 32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Comparatively, 1.7% of 60 Degrees Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is NAII or SXTP more profitable? Natural Alternatives International has a net margin of -6.56% compared to 60 Degrees Pharmaceuticals' net margin of -976.86%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Natural Alternatives International's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% 60 Degrees Pharmaceuticals -976.86%N/A -133.88% Which has preferable earnings & valuation, NAII or SXTP? Natural Alternatives International has higher revenue and earnings than 60 Degrees Pharmaceuticals. Natural Alternatives International is trading at a lower price-to-earnings ratio than 60 Degrees Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.19-$7.22M-$1.39-2.5260 Degrees Pharmaceuticals$300K19.13-$7.95M-$50.41-0.03 SummaryNatural Alternatives International and 60 Degrees Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTP vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.83M$2.59B$5.87B$10.13BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-0.0323.5374.5225.93Price / Sales19.13694.28537.17192.28Price / CashN/A171.1637.5660.44Price / Book-0.225.3712.166.29Net Income-$7.95M$32.95M$3.28B$270.77M7 Day Performance-0.71%1.28%0.87%3.88%1 Month Performance3.70%6.09%4.96%4.88%1 Year Performance-79.72%-2.15%60.74%26.01% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTP60 Degrees Pharmaceuticals2.378 of 5 stars$1.40-1.4%$3.00+114.3%-79.4%$5.83M$300K-0.033Positive NewsNAIINatural Alternatives International1.6423 of 5 stars$3.68-1.5%N/A-44.0%$22.71M$113.80M-2.64290Positive NewsShort Interest ↓Gap DownPASGPassage Bio3.9345 of 5 stars$7.11-0.3%$91.75+1,190.4%-53.1%$22.61MN/A-0.39130AKTXAkari Therapeutics3.7335 of 5 stars$0.70-7.9%$5.00+614.4%-76.1%$22.52MN/A0.009Analyst ForecastShort Interest ↓High Trading VolumeNNVCNanoViricides0.1536 of 5 stars$1.40+0.7%N/A-13.7%$22.50MN/A-1.9420Short Interest ↑NEUPNeuphoria Therapeutics2.57 of 5 stars$11.95+5.5%$21.00+75.7%N/A$22.47M$15.66M0.00N/ANews CoverageAnalyst ForecastSNYRSynergy CHC4.0739 of 5 stars$2.37-2.1%$10.00+321.9%+980.0%$22.37M$34.83M6.2440News CoverageCTXRCitius Pharmaceuticals2.3805 of 5 stars$1.29-3.0%$53.00+4,008.5%-90.6%$21.94MN/A0.0020Analyst UpgradeShort Interest ↑TAOXSynaptogenix0.1181 of 5 stars$6.21+6.7%N/AN/A$21.65M$3.96K-0.314Positive NewsSONNSonnet BioTherapeutics2.8845 of 5 stars$3.17-2.5%$20.00+530.9%-7.9%$21.65M$20K0.0010Positive NewsGap UpAYTUAytu BioPharma3.9582 of 5 stars$2.35flat$10.00+325.5%-6.3%$21.10M$81M-3.26160Positive NewsShort Interest ↓ Related Companies and Tools Related Companies NAII Competitors PASG Competitors AKTX Competitors NNVC Competitors NEUP Competitors SNYR Competitors CTXR Competitors TAOX Competitors SONN Competitors AYTU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTP) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTP Stock Alerts